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Preventable adverse events as a result of medical errors present a growing concern in the healthcare system. As drug-drug
interactions (DDIs) may lead to preventable adverse events, being able to extract DDIs from drug labels into a machine-
processable form is an important step toward effective dissemination of drug safety information. Herein, we tackle the problem
of jointly extracting drugs and their interactions, including interaction outcome, from drug labels. Our deep learning approach
entails composing various intermediate representations, including graph-based context derived using graph convolutions (GC)
with a novel attention-based gating mechanism (holistically called GCA), which are combined in meaningful ways to predict
on all subtasks jointly. Our model is trained and evaluated on the 2018 TAC DDI corpus. Our GCA model in conjunction with
transfer learning performs at 39.20% F1 and 26.09% F1 on entity recognition (ER) and relation extraction (RE) respectively on
the first official test set and at 45.30% F1 and 27.87% F1 on ER and RE respectively on the second official test set corresponding
to an improvement over our prior best results by up to 6 absolute F1 points. After controlling for available training data, the
proposed model exhibits state-of-the-art performance for this task.
CCS Concepts: • Information systems→ Information extraction; •Computingmethodologies→Multi-task learning;
Neural networks.
Additional Key Words and Phrases: Neural Networks, Multi-task Learning, Relation Extraction, Drug-Drug Interactions
1 INTRODUCTION
Preventable adverse events (AE) are negative consequences of medical care resulting in injury or illness in a
way that is generally considered avoidable. According to a report [14] by the Department of Human and Health
Services, based on an analysis of hospital visits by over a million Medicare beneficiaries, about one in seven
hospital visits were associated with an AE with 44% being considered clearly or likely preventable. Overall,
AEs were responsible for an estimated US $324 million in Medicare spending for the studied month of October
2008. Preventable AEs thus introduce a growing concern in the modern healthcare system as they represent a
significant fraction of hospital admissions and play a significant role in increased health care costs. Alarmingly,
preventable AEs have been cited as the eighth leading cause of death in the U.S., with an estimated fatality rate of
between 44,000 and 98,000 each year [13]. As drug-drug interactions (DDIs) may lead to to variety of preventable
AEs, being able to extract DDIs from prescription drug labels is an important effort toward effective dissemination
of drug safety information. This includes extracting information such as adverse drug reactions and drug-drug
interactions as indicated by drug labels. The U.S. Food and Drug Administration (FDA), for example, has recently
begun to transform Structured Product Labeling (SPL) documents into a computer-readable format, encoded in
national standard terminologies, that will be made available to the the medical community and the public [6].
The initiative to develop a database of structured drug safety information that can be indexed, searched, and
sorted is an important milestone toward a fully-automated health information exchange system.
To aid in this effort, we propose a supervised deep learning model able to tackle the problem of drug-drug
interaction extraction in an end-to-end fashion. While most prior efforts assume all drug entities are known
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Fig. 1. An example illustrating the end-to-end DDI extraction task. We first (1) identify mentions including precipitants;
for each precipitant, we (2) determine the type of interaction and, based on interaction type, (3) determine the interaction
outcome. In the case of PD interactions, the outcome corresponds to one of the previously identified effect spans.
ahead of time (more in Section 2), and the drug-drug interaction extraction task reduces to a simpler binary
relation classification task of known drug pairs, we propose a system able to identify drug mentions in addition
to their interactions. Concretely, the system takes as input the textual content of the label (indicating dosage
and drug safety precautions) of a target drug and, as output, identifies mentions of other drugs that interact
with the target drug. Thus only one of the two interacting drugs is known beforehand (i.e., the “label drug”),
while the other (i.e., the “precipitating drug”, or simply precipitant) is an unknown that our model is expected
to extract. Along with identifying precipitants, we also determine the type of interaction associated with each
precipitant; that is, whether the interaction is designated as being pharmacodynamic (PD) or pharmacokinetic
(PK). In pharmacology, PD interactions are associated with a consequence on the organism while PK interactions
are associated with changes in how one or both of the interacting drugs is absorbed, transported, distributed,
metabolized, and excreted when used jointly. Beyond identifying the interaction type, it is also important to
identify the outcome or consequence of an interaction. As defined, PK consequence can be captured using a small
fixed vocabulary, while identifying PD effects is a much more contrived process. The latter involves additionally
identifying spans of text correspond to a mention of a PD effect and linking each identified PD precipitants to
one or more PD effects. We provide a more formal description of the task in Section 3.1. Figure 1 features a
simple example of a PD interaction that is extracted from the drug label for Adenocard, where the precipitant is
digitalis and the effect is “ventricular fibrillation.”
To address this end-to-end variant of DDI extraction, we propose a multi-task joint-learning architecture
wherein various intermediate hidden representations, including sequence-based and graph-based contextual
representations based on bidirectional Long Short-Term Memory (BiLSTM) networks and graph convolution
(GC) networks respectively, are composed and are then combined in clever ways to produce predictions for
each subtask. GCs over dependency parse trees are useful for capturing long-distance syntactic dependencies.
We innovate on conventional GCs with a sigmoid gating mechanism derived via additive attention, referred to
as Graph Convolution with Attention-Gating (GCA), which determines whether or not (and to what extent)
information propagates between source and target nodes corresponding to edges in the dependency tree. The
attention component controls information flow by producing a sigmoid gate (corresponding to a value in [0, 1])
for each edge based on an attention-like mechanism that measures relevance between node pairs. Intuitively,
some dependency edges are more relevant than others; for example, negations or adjectives linked to important
nouns via dependency edges may have a large influence on the overall meaning of a sentence while articles, such
as “the”, “a”, and “an”, have little or no influence comparatively. A standard GC would compose all source nodes
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Table 1. Characteristics of various datasets
*DDI2013 *NLM180 TR22 Test Set 1 Test Set 2
Number of Drug Labels 715 180 22 57 66
Total number of sentences 6489 5757 603 8195 4256
Number of sentences per Drug Label (Average) 9 32 27 144 64
Number of words per sentence (Average) 21 23 24 22 23
Proportion of sentences with annotations 70% 27% 51% 23% 23%
Number of mentions per annotated sentence (Average) 2.3 4.0 3.8 3.7 3.6
Proportion of mentions that are Precipitant 100% 57% 53% 56% 55%
Proportion of mentions that are Trigger - 20% 28% 30% 33%
Proportion of mentions that are Effect - 23% 19% 14% 12%
Proportion of interactions that are Pharmacodynamic 14% 47% 49% 33% 28%
Proportion of interactions that are Pharmacokinetic 9% 25% 21% 28% 47%
Proportion of interactions that are Unspecified 77% 28% 30% 39% 25%
* Statistics for NLM180 and DDI2013 were computed on mapped examples (based on our own annotation mapping scheme) and not based on
the original data.
with equal weighting, while the GCA would be more selective by possibly assigning a higher sigmoid value to
negations/adjectives and a lower sigmoid value to articles.
We train and evaluate our model on the Text Analysis Conference (TAC) 2018 dataset for drug-drug interaction
extraction from drug labels [6]. The training data contains 22 drug labels, referred to as TR22, with gold standard
annotations. As training data is scarce, we additionally propose a transfer learning step whereby the model is
first trained on external data for extracting DDIs including the NLM-DDI CD corpus1 and SemEval-2013 Task
9 dataset [8]; we refer to these as NLM180 and DDI2013 respectively. Two official test sets of 57 and 66 drug
labels, referred to as Test Set 1 and 2 respectively, with gold standard annotations are used strictly for evaluation.
Table 1 contains more information about these datasets and their characteristics. In this study, we show that the
GCA improves over the standard GC and that our GCA based model with transfer learning by pretraining on
external data improves over our the best model [27] from a prior study2, that is based solely on BiLSTMs, by 4
absolute F1 points in overall performance. Furthermore, we show that our GCA based model complements our
prior BiLSTM model; that is, by combining the two via ensembling, we improve over the prior best by 6 absolute
F1 points in overall performance. Among comparable methods, our GCA based method exhibits state-of-the-art
performance on all metrics after controlling for available training data. Our code3 is available for review and will
be made publicly available on GitHub.
2 RELATED WORKS
Prior studies on DDI extraction have focused primarily on binary relation extraction where drug entities are
known during test time and the learning objective is reduced to a simpler relation classification (RC) task. In
RC, pairs of known drug entities occurring in the same sentence are assigned a label, from a fixed set of labels,
indicating relation type (including the none or null relation). Typically, no preliminary drug entity recognition or
additional consequence prediction step is required. In this section, we cover prior relation extraction methods for
DDI as well as participants of the initial TAC DDI challenge.
1https://lhce-brat.nlm.nih.gov/NLMDDICorpus.htm
2Tran et al. [27] was published as part of the non-refereed Text Analysis Conference (TAC); this study is an extension of our original report.
3http://tttran.net/code/gcn-ddi2019.zip
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2.1 Relation Extraction for DDI
State-of-the-art methods for DDI extraction typically involve some variant of convolutional neural networks
(CNNs) or recurrent neural networks (RNNs), or a hybrid of the two. Many studies utilize the dependency parse
structure of an input sentence to capture long-distance dependencies, which has previously been shown to
improve performance in general relation extraction tasks [29] and those in the biomedical domain [17, 19]. Liu
et al. [18] first proposed the use of standard CNNs for DDI extraction. Their approach involved convolving
over an input sentence with drug entities bound to generic tokens in conjunction with so called position vectors.
Position vectors are used to indicate the offset between a word and each drug of the pair and provide additional
spatial features. Improvements were attained, in a follow-up study, by instead convolving over the shortest
dependency path between the candidate drug pair [17]. Zhao et al. [30] introduced an enhanced version of the
CNN based method by deploying word embeddings that were pretrained on syntactic parses, part-of-speech
embeddings, and traditional handcrafted features. Suárez-Paniagua et al. [24] instead focused on fine-tuning
various hyperparameter settings including word and position vector dimensions and convolution filter sizes for
improved performance. Kavuluru et al. [10] introduced the first neural architecture for DDI extraction based
on hierarchical RNNs, wherein hidden intermediate representations are composed in a sequential fashion with
cyclic connections, with character and word-level input. Sahu and Anand [22] experimented with various ways
of composing the output of a bidirectional LSTM network including max-pooling and attention pooling. Lim
et al. [16] proposed a recursive neural network architecture using recurrent units called TreeLSTMs to produce
meaningful intermediate representations that are composed based on the structure of the dependency parse
tree of a sentence. Asada et al. [2] demonstrated that combining representations of a CNN over the input text
and graph convolutions over the molecular structure of the target drug pair (as informed by an external drug
database) can result in improved DDI extraction performance. More recently, Sun et al. [25] proposed a hybrid
RNN/CNN method by convolving over the contextual representations produced by a preceding recurrent neural
network.
2.2 TAC 2018 DDI Track
TAC is a series of workshops organized by NIST aimed at encouraging research in natural language processing
(NLP) by providing large test collections along with a standard evaluation procedure. The “DDI Extraction from
Drug Labels” track [6] is established with the goal of transforming the contents of drug labels into a machine-
processable format with linkage to standard terminologies. Tang et al. [26] placed first in the challenge using an
encoder/decoder architecture to jointly identify precipitants and their interaction types and a rule-based system
to determine interaction outcome. In addition to the provided training data, they downloaded and manually
annotated a collection of 1148 sentences to be used as external training data. Tran et al. [27] placed second in the
challenge using a BiLSTM for joint entity recognition and interaction type prediction, followed by a CNN with
two separate dense output layers (one of PK and one for PD) for outcome prediction. Dandala et al. [5] placed
third in the challenge using a BiLSTM (with CRFs) with part-of-speech and dependency features as input for
entity recognition. Next, an Attention-LSTM model was used to detect relations between recognized entities. The
embeddings were pretrained on a corpus of FDA-released drug labels and used to initialized the model. NLM180
was used for training with TR22 serving as the development set. Other participants proposed systems involving
similar approaches including BiLSTMs and CNNs as well as traditional linear and rule-based methods.
3 MATERIALS AND METHODS
We begin by formally describing the end-to-end task in Section 3.1. Next, we describe our approach to framing
and modeling the problem (Section 3.2), the proposed network architecture (Section 3.4), the data used for transfer
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Table 2. Example of the sequence labeling scheme for the sentence in Figure 1, where LABELDRUG is substitute for Adenocard.
O O O O O O O U-DYN
The use of LABELDRUG in patients receiving digitalis
O O O B-TRI L-TRI B-EFF L-EFF O
may be rarely associated with ventricular fibrillation .
learning (Section 3.5), and our model-ensembling approach (Section 3.6). Finally, in Section 3.7, we describe the
method for model evaluation.
3.1 Task Description
Herein, we describe the end-to-end task of automatically detecting drugs and their interactions, including the
outcome of identified interactions, as conveyed in drug labels. We first define drug label as a collection of sections
(e.g., DOSAGE & ADMINISTRATION, CONTRAINDICATIONS, and WARNINGS) where each section contains one or
more sentences. The overall task, in essence, involve fundamental language processing techniques including
named entity recognition (NER) and relation extraction (RE). The first subtask of NER is focused on identifying
mentions in the text corresponding to precipitants, interaction triggers, and interaction effects. Precipitating
drugs (or simply precipitants) are defined as substances, drugs, or a drug class involved in an interaction. The
second subtask of RE is focused on identifying sentence-level interactions; specifically, the goal is to identify
the interacting precipitant, the type of the interaction, and outcome of the interaction. The interaction outcome
depends on the interaction type as follows. Pharmacodynamic (PD) interactions are associated with a specified
effect corresponding to a span within the text that describes the outcome of the interaction. Figure 1 features a
simple example of a PD interaction that is extracted from the drug label for Adenocard, where the precipitant is
digitalis and the effect is “ventricular fibrillation.” Naturally, it is possible for a precipitant to be involved in multiple
PD interactions. Pharmacokinetic (PK) interactions, on the other hand, are associated with a label from a fixed
vocabulary of National Cancer Institute (NCI) Thesaurus codes indicating various levels of increase/decrease in
functional measurements. For example, consider the sentence: “There is evidence that treatment with phenytoin
leads to decrease intestinal absorption of furosemide, and consequently to lower peak serum furosemide
concentrations.” Here, phenytoin is involved in a PK interaction with the label drug, furosemide, and the type of
PK interaction is indicated by the NCI Thesaurus code C54615 which describes a decrease in the maximum serum
concentration (Cmax) of the label drug. Lastly, unspecified (UN) interactions are interactions with an outcome that
is not explicitly stated in the text and is typically indicated through cautionary remarks.
3.2 Joint Modeling Approach
Since only precipitants are annotated in the ground truth, we model the task of precipitant recognition and
interaction type prediction jointly. We accomplish this by reducing the problem to a sequence tagging problem via
a novel NER tagging scheme. That is, for each precipitant drug, we additionally encode the associated interaction
type. Hence, there are three possible precipitant tags:DYN,KIN, andUN for precipitants with pharmacodynamic,
pharmacokinetic, and unspecified interactions respectively. Two more tags, TRI and EFF, are added to further
identify mentions of triggers and effects concurrently. To properly identify boundaries, we employ the BILOU
encoding scheme [21]. In the BILOU scheme, B, I, and L tags are used to indicate the beginning, inside, and last
token of a multi-token entity respectively. The U tag is used for unit-length entities while the O tag indicates
that the token is outside of an entity span. As a preprocessing step, we identify the label drug in the sentence, if
it is mentioned, and bind it to a generic entity token (e.g., “LABELDRUG”). We also account for indirect mentions
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of the label drug, such as the generic version of a brand-name drug, or cases where the label drug is referred to
by its drug class. To that end, we built a lexicon of drug names mapped to alias using NLM’s Medical Subject
Heading (MeSH) tree as a reference. Table 2 shows how the tagging scheme is applied to a simple example.
Once we have identified the precipitant (as well as triggers/effects) and the interaction type for each precipitant,
we subsequently predict the outcome or consequence of the interaction (if any). To that end, we consider all
entity spans annotated with KIN tags and assign them a label from a static vocabulary of 20 NCI concept
codes corresponding to PK consequence (i.e., multi-class classification). Likewise, we consider all entity spans
annotated withDYN tags and link them to mention spans annotated with EFF tags; we accomplish this via binary
classification of all pairwise combinations. For entity spans annotated with UN tags, no additional outcome
prediction is needed.
3.3 Notations and Neural Building Blocks
In this section, we describe notations used in the remainder of this study. In addition, we provide a generic
definition of the canonical CNN and BiLSTM networks that are later used as building blocks in model construction.
For ease of notation, we assume fixed sentence length n and word length nˆ; in practice, we set n and nˆ to be the
maximum sentence/word length and zero-pad shorter sentences/words. Moreover, we use square brackets with
matrices to indicate a row indexing operation; for example, X [i] denotes the vector corresponding to the ith row
of matrix X .
Henceforth, the abstract function f w,doutCNN (·) : Rn×din 7→ Rdout is used to represent the CNN that convolves on a
window of size w in a sentence with n words, mapping an n × din matrix to a vector representation of length
dout, where din is the word embedding size. This is an abstraction of the canonical CNN for NLP first proposed
by Kim [12] and is defined as follows. First, we denote the convolution operation⋆ as the sum of the element-wise
products of two matrices. That is, for two matrices A and B of same dimensions, A ⋆ B =
∑
j
∑
k Aj,k · Bj,k .
Suppose the input is a sequence of vector representations x1, . . . , xn ∈ Rdin ; the output representation g ∈ Rdout
is defined such that
gk = max( fconvolve(k, x1, . . . , xw ) , . . . ,
fconvolve(k, xn−w+1, . . . , xn) )
for k = 1, . . . ,dout,
given a convolution function fconvolve that convolves over a contiguous window of sizew ≤ n, defined as
fconvolve(k, v1, . . . , vw ) = ReLU
©­­«W k ⋆
©­­«
v1
...
vw
ª®®¬ + bk
ª®®¬
where v1, . . . , vw ∈ Rdin are input vectors,W k ∈ Rw×din and bk ∈ R for k = 1, . . . ,dout, are network parameters
(corresponding to a set of dout convolutional filters), ReLU(x) = max(0,x) is the linear rectifier activation function.
Here, dout is a hyperparameter that determines the number of convolutional filters and thus the size of the final
feature vector. In the study, we denote the convolution as an abstract function f w,doutCNN (·) : Rn×din 7→ Rdout that
convolves on a window of sizew and maps an n × din matrix to a vector representation of length dout.
Likewise, we represent the BiLSTM network as an abstract function f doutBLSTM(·) : Rn×din 7→ Rn×dout that maps a
sequence of n input vectors (e.g., word embeddings) of din size (as an n×din matrix) to a corresponding sequence of
n output context vectors of dout size (as an n×dout matrix). Let −−−−→LSTM and←−−−−LSTM represent an LSTM composition in
the forward and backward direction. Suppose the input is a sequence of vector representations x1, . . . , xn ∈ Rdin ;
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Fig. 2. Overview of the neural network architecture for a simplified example from the drug label Adenocard. Here, the ground
truth indicates that digitalis is a pharmacodynamic precipitant associated with the effect “ventricular fibrillation.” The PK
predictive component is omitted given there are no precipitants involved in a PK interaction.
the output of a standard bidirectional LSTM network (BiLSTM) is a matrix H ∈ Rn×dout = (h1, . . . , hn )⊤ such that
−→
h i =
−−−−→LSTM(xi ),
←−
h i =
←−−−−LSTM(xi ),
hi =
−→
h i ∥ ←−h i , for i = 1, . . . ,n,
where ∥ is the vector concatenation operator and hi ∈ Rdout represents the context centered at the ith word.
Here, dout is a hyperparameter that determines the size of the the context embeddings. In the study, we denote
the BiLSTM network as an abstract function f doutBLSTM(·) : Rn×din 7→ Rn×dout that maps a sequence of n input vectors
(e.g., word embeddings) of din size (as an n × din matrix) to a corresponding sequence of n output context vectors
of dout size (as an n × dout matrix).
3.4 Neural Network Architecture and Training Details
We begin by describing how the three types of intermediate representations are composed. The construction of
word, context, and graph-based representations are described in Sections 3.4.1, 3.4.2, and 3.4.3 respectively. Next,
we describe the predictive components of the network that share and utilize the intermediate representations.
In Section 3.4.4, we describe the sequence-labeling component of the network used to extract drugs and their
interactions. In Section 3.4.5, we describe the component for predicting interaction outcome. An overview of the
architecture is shown in Figure 2. Lastly, we describe the model configuration and training process in Section 3.4.6.
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3.4.1 Word-level Representation. Suppose the input is a sentence of length n represented by a sequence of word
indicesw1, . . . ,wn into the vocabularyVWord. Each word is mapped to a word embedding vector via embedding
matrices EWord ∈ R |VWord |×δ such that δ is a hyperparameter that determines the size of word embeddings.
In addition to word embeddings, we employ character-CNN based representations as commonly observed in
recent neural NER models [4]. Character-based models capture morphological features and help generalize
to out-of-vocabulary words. For the proposed model, such representations are composed by convolving over
character embeddings of size π using a window of size 3, producing η feature maps; the feature maps are then
max-pooled to produce η-length feature representations. Correspondingly, we denote EChar ∈ R |VChar |×π as the
embedding matrix given the character vocabularyVChar; the character-level embedding matrix Ci ∈ Rnˆ×π for
the word at position i is
Ci =
©­­«
EChar[ci,1]
...
EChar[ci,nˆ]
ª®®¬
where ci, j for 1 ≤ i ≤ n, 1 ≤ j ≤ nˆ, represents the jth character index of the ith word. The word-level representation
Rword ∈ Rn×(δ+η) is a concatenation of character-based word embeddings and pretrained word embeddings along
the feature dimension; formally,
RWord =
©­­«
EWord[w1] ∥ f 3,ηCNN(C1)
...
EWord[wn] ∥ f 3,ηCNN(Cn)
ª®®®¬ .
3.4.2 Context-based Representation. We compose context-based representation by simply processing the word-
level representation with a BiLSTM layer as is common practice; concretely, RContext = f ρBLSTM(RWord) where ρ is
a hyperparameter that determines the size of the context embeddings.
3.4.3 Graph-based Representation. In addition to the sequential nature of LSTMs, we propose an alternative
and complementary graph-based approach for representing context using graph convolution (GC) networks.
Typically composed on dependency parse trees, graph-based representations are useful for relation extraction
as they capture long-distance relationships among words of a sentence as informed by the sentence’s syntactic
dependency structure. While graph convolutions are typically applied repeatedly, our initial cross-validation
results indicate that single-layered GCs are sufficient and deep GCs typically resulted in performance degradation;
moreover, Zhang et al. [29] report good performance with similarly shallow GC layers. Hence the following
formulation describes a single-layered GC network, with an additional attention-based sigmoid gating mechanism,
which we holistically refer to as a Graph Convolution with Attention-Gating (GCA) network. Initially motivated
in Section 1, the GCA improves on conventional GCs with a sigmoid-gating mechanism derived via an alignment
score function associated with additive attention [3]. The sigmoid “gate” determines whether or not (and to
what extent) information is propagated based on a learned alignment function that conceives a “relevance” score
between a source and target node (more later).
As a pre-processing step, we use a dependency parsing tool to generate the projective dependency tree for
the input sentence. We represent the dependency tree as an n × n adjacency matrix A where Ai, j = Aj,i = 1 if
there is a dependency relation between words at positions i and j. This matrix controls the flow of information
between pairs of words corresponding to connected nodes in the dependency tree (ignoring dependency type);
however, it is also important for the existing information of each node to carry over on each application of the
GC. Hence, as with prior work [29], we use the modified version A˜ = A+ I where I is the identity matrix to allow
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for self-loops in the GC network. The graph-based representation RGraph ∈ Rn×β is composed such that
RGraph[i] = tanh
(
n∑
j=1
A˜i, jW
GraphRContext[j] + bGraph
)
whereW Graph ∈ Rβ×ρ , bGraph ∈ Rβ are network parameters, tanh(·) is the hyperbolic tangent activation function,
and β is a hyperparameter that determines the hidden GC layer size. Thus, information propagated from source
nodes j = 1, . . . ,n to target node i , based on the summation of intermediate representations, are unweighted and
share equal importance.
As stated previously, we propose to extend the standard GC by adding an attention-based sigmoid gating
mechanism to control the flow of information via the gating matrix G ∈ Rn×n . We define G such that
Gi, j = σ (v · ai, j ) for i = 1, . . . ,n, j = 1, . . . ,n,
where v ∈ Rα is a network parameter and ai, j ∈ Rα is the hidden attention layer composed as a function of the
context representation at source node i and target node j; concretely,
ai, j = tanh
(
W SourceRContext[i] +W TargetRContext[j] + bAttn
)
,
whereW Source,W Target ∈ Rα×ρ and bAttn ∈ Rα are network parameters and α is a hyperparameter that determines
hidden attention layer size. Intuitively, the network learns the relevance of node i to node j via the attention
ai, j and outputs a between 0 and 1 at gate Gi, j . Gate Gi, j controls the flow of information from node i to j,
where 0 indicates no information is passed and 1 indicates that all information is passed. To integrate the gating
mechanism, we simply redefine A˜ = (A + I ) × G. In the next two sections, we show how the intermediate
representations are used for end-task prediction.
3.4.4 Sequence Labeling. The sequence labeling (SL) task for detecting precipitant drugs and their interaction
type is handled by a bidirectional LSTM trained on a combination of the two types of losses: conditional random
fields (CRF) and softmax cross entropy (SCE). Using CRFs results in choosing a globally optimal assignment of
tags to the sequence, whereas a standard softmax at the output of each step may result in less globally consistent
assignments (e.g., an L tag following an O tag) but better local or partial assignments. We begin by introducing
a bidirectional LSTM layer that processes the various intermediate representations. The new representation,
RSL ∈ Rn×γ , is defined such that
RSL = f
γ
BLSTM
©­­«
RWord[1] ∥ RContext[1] ∥ RGraph[1]
...
RWord[n] ∥ RContext[n] ∥ RGraph[n]
ª®®¬
where γ is a hyperparameter that determines the hidden layer size. While RGraph is based on RContext and RContext
is based on RWord, we observed that combining these intermediate representations (manifesting at varying depth
in the architecture) resulted in improved sequence-labeling performance according to preliminary experiments
and prior results from Tran et al. [27]. As with residual networks [7], they additionally provide a kind of shortcut
or “skip-connection” over intermediate layers.
Given a set of ntag possible tags, we compose an n × ntag score matrix Y (where Yi,t represents the score of
the t th tag at position i) such that Y [i] = W OutRSL[i] + bOut whereW Out ∈ Rntag×γ , bOut ∈ Rntag are network
parameters. Given example x and the truth tag assignment as a matrix Y¯ where rows are one-hot vectors over all
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possible tags, the SCE loss is
ℓSCE(x , A˜, Y¯ ;θ ) = −
n∑
i=1
ntags∑
t=1
Y¯i,t log
(
exp(Yi,t )∑ntags
k=1 exp(Yi,k )
)
where Y¯i,t ∈ {0, 1} indicates whether the tag t is assigned at position i and θ is the set of all network parameters.
Next, we define the CRF loss as commonly used with LSTM based models for entity recognition. We learn a
transition score matrixM ∈ Rntag×ntag , inferred from the training data, such thatMi, j is the transition score from
tag i to tag j. Given an example x as a sequence of word indicesw1, . . . ,wn and candidate tag sequence y¯ as a
sequence of tag indices s1, . . . , sn , the tag assignment score (t-score) is defined as
t-score (x , A˜, y¯; θˆ ) = t-score (w1, . . . ,wn , A˜, s1, . . . , sn ; θˆ ) =
n∑
i=1
(
Yi,si +Msi−1,si
)
where θˆ = θ ∪ {M}. Intuitively, this score summarizes the likelihood of observing a transition from tag si−1 to
tag si in addition to the likelihood of emitting tag si given the semantic context for i = 1, . . . ,n. Thus Y is treated
as a matrix of emission scores for the CRF. For an example with input x and truth tag assignment y¯, the loss is
computed as the negative log-likelihood of the tag assignment as informed by the normalized tag assignment
score, or
ℓCRF(x , A˜, y¯; θˆ ) = − log exp(t-score(x , A˜, y¯; θˆ ))∑
y∈S exp(t-score(x , A˜,y; θˆ ))
where S is the set of all possible tag assignments. The final per-example loss for sequence labeling is simply a
summation of the two losses: ℓSL = ℓSCE + ℓCRF. During testing, we use the Viterbi algorithm [28], a dynamic
programming approach, to decode and identify the globally optimal tag assignment.
3.4.5 Consequence prediction. Once precipitants (and corresponding interaction types) have been identified, we
perform so called consequence prediction (CP) for all precipitant drugs identified as participating in PD or PK
interactions. The classification task of CP takes as input the target sentence and two candidate entities that are
referred to as the subject and object entities. Here the subject is always a precipitating drug; on the other hand,
the object designation depends on the type of interaction (more later). First, we define the representation matrix
for CP as RCP ∈ Rn×(ρ+β ) where
RCP =
©­­«
RContext[1] ∥ RGraph[1]
...
RContext[n] ∥ RGraph[n]
ª®®¬ .
We process the matrix via convolutions of windows sizes 3, 4, and 5 and concatenate the results to produce the
final feature vector gCP. In addition to CNN features, we map entities to their graph based context features and
append it to gCP, which has been previously shown to work well in a similar architecture [15]. Concretely, the
final feature vector is
gCP = f 3,µCNN(RCP) ∥ f 4,µCNN(RCP) ∥ f 5,µCNN(RCP) ∥ RCP[tSub] ∥ RCP[tObj]
with gCP ∈ R3µ+2(ρ+β ) where µ, as a hyperparameter, is the number of CNN filters per convolution and tSub and
tObj are the position index of the last word (typically the “head” word) of the subject and object respectively.
The actual entities determined to be the subject/object pair are based on the interaction type; for PD interactions,
the subject is the precipitant drug and the object is some candidate effect mention. For PK interactions, however,
the subject is the precipitant drug but the object is chosen to be the closest (based on character-offset) mention of
the drug label with respect to the target precipitant drug. We found this appropriate based on manual review
of the data, as the NCI code being assigned depends highly on whether the increase/decrease in functional
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Table 3. Model configuration obtained through random search over 11-fold cross-validation of TR22 (training data).
Setting Value
Learning Rate 0.001
Dropout Rate 0.5
Character Embedding Size (π ) 25
Character Representation Size (η) 50
Word Embedding Size (δ ) 200
Setting Value
Context Embedding Size (ρ) 100
GC Hidden Size (β) 100
GC Attention Size (α ) 25
Sequence LSTM Hidden Size (γ ) 200
Outcome CNN Filter Count (µ) 50
measurements is with respect to the label drug or the precipitant drug. In case the label drug is not mentioned, a
generic “null” vector is used to represent the object.
When performing sequence labeling, we pass in the entire dependency tree encoded as the matrix A˜. However,
when performing consequence prediction and both entities are non-null, we pass in a pruned version of the entire
tree that is tailored to the entity pair. We apply the same pruning strategy proposed by Zhang et al. [29], wherein
for a pair of subject and object entities (corresponding to tSub and tObj), we keep only nodes either along or within
one hop of the shortest dependency path. This prevents distant and irrelevant portions of the dependency tree
from influencing the model while retaining important modifying and negating terms. Thus the notation A˜Sub↔Obj
is used to denote the pruned version of A˜ as a function of the entity pair indicated by tSub and tObj.
To determine whether there is a PD interaction between a pair of entities, we employ a standard binary
classification output layer. Concretely, for example sentence xˆ and output y ∈ {0, 1}, the probability of a PD
interaction between the entity pair is q = sigmoid(wPD · gCP + bPD) where wPD ∈ R3µ+2(ρ+β ) and bPD ∈ R are
network parameters. The associated binary cross entropy loss is
ℓPD(x , A˜Sub↔Obj, yˆ;θ ) = yˆ logq + (1 − yˆ) log(1 − q)
where yˆ ∈ {0, 1} indicates the ground truth. For PK interactions, we instead use a softmax function to produce a
probability distribution, represented as vector q ∈ R20, over the 20 labels corresponding to NCI Thesaurus codes.
Concretely, the predicted probability of label j is qj = exp(yPKj )/exp(
∑20
k=1 y
PK
k ) where yPK =W PKgCP + bPK and
W PK ∈ R20×[3µ+2(ρ+β )] and bPK ∈ R20 are network parameters. Given a one-hot vector y¯ ∈ R20 indicating the
ground truth, the associated softmax cross entropy loss is
ℓPK(x , A˜Sub↔Obj, y¯;θ ) =
20∑
j=1
y¯j log qj .
The loss for a batch of examples is simply the sum of its constituent example-based losses.
3.4.6 Neural Network Configuration and Training Details. For each training iteration, we randomly sample 10
sentences from the training data. These are re-composed into three sets of task-specific examples S, D, and
K corresponding to the tasks of sequence labeling, PD prediction, and PK prediction respectively. Unlike our
prior work, in which the sub-tasks were trained in an interleaved fashion, we train on all three objectives jointly.
Here, we dynamically switch between one of four training objective losses based on whether there are available
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training examples (in the batch and for the current iteration) for each task. The final training loss is then
ℓ =

∑
x ∈S
ℓSL(x) + ∑
x ∈D
ℓPD(x) + ∑
x ∈K
ℓPK(x) if |D| > 0 and |K | > 0,∑
x ∈S
ℓSL(x) + ∑
x ∈K
ℓPK(x) if |D| = 0 and |K | > 0,∑
x ∈S
ℓSL(x) + ∑
x ∈D
ℓPD(x) if |D| > 0 and |K | = 0,∑
x ∈S
ℓSL(x) otherwise.
We train the network for a maximum of 10,000 iterations, check-pointing and evaluating every 100 iterations
on a validation set of sentences from four held-out drug labels. Only the checkpoint that performed best on
the validation set is kept for test time evaluation. The choice of hyperparameters is shown in Table 3; discrete
numbered parameters corresponding to embedding or hidden size were chosen from {10, 25, 50, 100, 200, 400}
based on random search and optimized by assessing 11-fold cross-validation performance on TR22. The learning
and dropout rates are set to typical default values. We used Word2Vec embeddings pretrained on the corpus of
PubMed abstracts [20]. All other variables are initialized using values drawn from a normal distribution with
a mean of 0 and standard deviation of 0.1 and further tuned during training. Words were tokenized on both
spaces and punctuation marks; punctuation tokens were kept as is common practice for NER type systems. For
dependency parsing, we use SyntaxNet4 which implements the transition-based neural model by Andor et al.
[1]. We trained the aforementioned parser, using default settings, on the GENIA corpus [11] and use it to obtain
projective dependency parses for each example.
3.5 Transfer Learning with Network Pre-Training
An obstacle in solving this flavor of DDI extraction as a machine learning problem is the high potential for
overfitting given the sparse nature of the output space, which is further intensified by the scarce availability of
high quality training data. As quality training data is expensive and requires domain expertise, we propose to use
a transfer learning approach where the model is pre-trained on external data as follows. First, we pre-train on
the DDI2013 dataset, which contains strictly binary relation DDI annotations and no interaction consequence
annotation. Hence, DDI2013 is only used to train the sequence labeling objective ℓSL(x). Next, we pre-train on
NLM180, a collection of 180 drug labels annotated in a comparable format to TR22 but follows a different set of
guidelines and lacks comprehensive interaction consequence annotation. Finally, we fine-tune for the target task
by training on the official TR22 dataset.
Translating NLM180 and DD2013 to the TAC 2018 format is an imperfect process given structural (breadth and
depth of annotations) and semantic (guidelines in addition to annotator experience and vision) differences. For
example, differences in how entity boundaries are annotated, such as whether or not modifier terms should be
kept as part of a named entity, may have a large impact on model performance. Hence, we expect the translated
versions of NLM180 and DDI2013 to be very noisy as training examples for the target task. We describe the
translation process for DDI2013 in Sections 3.5.1 and 3.5.2. We provide summary statistics about these datasets in
Table 1.
3.5.1 NLM180 Mapping Scheme. In NLM180, there is no distinction between triggers and effects; moreover, PK
effects are limited to coarse-grained (binary) labels corresponding to increase or decrease in function measurements.
Hence, a direct mapping from NLM180 to the TR22 annotation scheme is impossible. As a compromise, NLM180
“triggers” were mapped to TR22 triggers in the case of unspecified and PK interactions. For PD interactions, we
instead mapped NLM180 “triggers” to TR22 effects, which we believe to be appropriate based on our manual
4https://github.com/tensorflow/models/tree/master/research/syntaxnet
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analysis of the data. Since we do not have both trigger and effect for every PD interaction, we opted to ignore
trigger mentions altogether in the case of PD interactions to avoid introducing mixed signals. While trigger
recognition has no bearing on relation extraction performance, this policy has the effect of reducing the recall
upperbound on NER by about 25% based on early cross-validation results. To overcome the lack of fine-grained
annotations for PK outcome in NLM180, we deploy the well-known bootstrapping approach [9] to incrementally
annotate NLM180 PK outcomes using TR22 annotations as a starting point. To mitigate the problem of semantic
drift, we re-annotated by hand iterative predictions that were not consistent with the original NLM180 coarse
annotations (i.e., active learning [23]).
3.5.2 DDI2013 Mapping Scheme. The DDI2013 dataset contains annotations that are incomplete with respect to
the target task; specifically, annotations are limited to typed binary relations between any two drug mentioned
drugs in the sentence (and not necessary between a mentioned drug and the label drug) without outcome or
consequence prediction. In DDI2013, there are four types of interactions: mechanism, effect, advice and int. The
mechanism type indicates that a PK mechanism is being discussed; effect indicates that the consequence of a PD
interaction is being discussed; advice indicates suggestions regarding the handling of the drugs; and int is an
interaction without any specific additional information. We translate the annotation by first applying a filtering
step on all interactions such that it conforms to the target task; namely, we filter such that only interactions
involving the label drug is kept. The non-label drug entity is then annotated as a precipitant with an interaction
tag based on the following mapping scheme. Entities involved in a mechanism relation with the drug label are
treated as KIN precipitants; likewise, entities in effect and advice relations are treated as DYN precipitants and
int relations are treated as UNK precipitants. As there is no consequence annotation, the mapped examples are
used to train the sequence labeling objective but not the other objective.
3.6 Voting-based Ensembling
Our prior effort [27] showed that model ensembling resulted in optimal performance for this task. Hence, model
ensembling remains a key component of the proposed model. Our ensembling method is based on ensembling
over ten models each trained with randomly initialized weights and a random development split. Intuitively,
models collectively “vote” on predicted annotations that are kept and annotations that are discarded. A unique
annotation (entity or relation) has one vote for each time it appears in one of the ten model prediction sets. In
terms of implementation, unique annotations are incrementally added (to the final prediction set) in order of
descending vote count; subsequent annotations that conflict (i.e., overlap based on character offsets) with existing
annotations are discarded. Hence, we loosely refer to this approach as “voting-based” ensembling.
3.7 Model Evaluation
We used the official evaluation metrics for NER and relation extraction based on the standard precision, recall,
and F1 micro-averaged over exactly matched entity/relation annotations. We use the strictest matching criteria
corresponding to the official “primary” metric (of the TAC DDI task), as opposed to the “relaxed” metric that
ignores mention and interaction type. Concretely, the matching criteria for entity recognition considers entity
bounds as well as the type of the entity. The matching criteria for relation extraction comprehensively considers
precipitant drugs and, for each, the corresponding interaction type and interaction outcome. As relation extraction
evaluation takes into account the bounds of constituent entity predictions, relation extraction performance is
heavily reliant on entity recognition performance. On the other hand, we note that while NER evaluation considers
trigger mentions, triggers are ignored when evaluating relation extraction performance. Two test sets of 57 and
66 drug labels, referred to as Test Set 1 and 2 respectively, with gold standard annotations are used for evaluation.
Next, we discuss the differences between these test sets. As shown in Table 1, Test Set 1 closely resembles TR22
with respect to the sections that are annotated. However, Test Set 1 is more sparse in the sense that there are more
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Table 4. Main results based on 95% confidence interval around mean precision, recall, and F1 based on evaluating N=100
ensembles for each model.
Test 1 / Entity Test 1 / Relation Test 2 / Entity Test 2 / Relation Overall
Method Training Data P (%) R (%) F (%) P (%) R (%) F (%) P (%) R (%) F (%) P (%) R (%) F (%) P (%) R (%) F (%)
BL TR22 23.82 42.04 30.39 14.74 18.38 16.35 26.15 39.69 31.51 12.48 15.43 13.79 19.30 ± 0.12 28.88 ± 0.12 23.01 ± 0.06
GCA TR22 32.87 32.35 32.59 22.70 13.95 17.27 38.82 31.31 34.65 19.26 11.63 14.49 28.41 ± 0.09 22.31 ± 0.16 24.75 ± 0.11
BL(1) TR22 + NLM180 27.05 39.87 32.22 19.94 22.20 21.00 32.49 41.92 36.60 21.82 23.93 22.82 25.32 ± 0.09 31.98 ± 0.11 28.16 ± 0.06
GCA TR22 + NLM180 38.30 31.20 34.38 27.97 15.14 19.63 44.13 31.18 36.53 31.79 15.76 21.06 35.55 ± 0.18 23.32 ± 0.20 27.90 ± 0.17
BL TR22 + NLM180 + DDI2013 29.27 41.93 34.47 22.93 25.42 24.11 38.73 43.79 41.10 27.11 27.32 27.21 29.51 ± 0.10 34.61 ± 0.10 31.72 ± 0.06
GCA TR22 + NLM180 + DDI2013 41.58 38.24 39.83 31.84 20.49 24.93 47.54 36.12 41.04 32.07 17.81 22.90 38.26 ± 0.16 28.17 ± 0.12 32.18 ± 0.12
GC(2) TR22 + NLM180 + DDI2013 38.85 36.30 37.52 29.82 18.59 22.88 43.74 34.88 38.80 31.14 16.40 21.48 35.89 ± 0.20 26.54 ± 0.20 30.17 ± 0.19
GCA + BL(3) TR22 + NLM180 + DDI2013 35.22 44.23 39.20 27.58 24.77 26.09 45.50 45.10 45.30 31.69 24.89 27.87 35.00 ± 0.15 34.75 ± 0.13 34.61 ± 0.10
(1) Our original challenge submission using a BiLSTM-based approach and trained on only TR22 and NLM180.
(2) For reference, we include an evaluation of the standard GC without attention-gating.
(3) Our current best is a combination of GCA and BL by ensembling.
Table 5. Comparison of our method with comparable (based on training data) methods of teams in the top 5.
Test 1 / Entity Test 1 / Relation Test 2 / Entity Test 2 / Relation
Method Training Data P (%) R (%) F (%) P (%) R (%) F (%) P (%) R (%) F (%) P (%) R (%) F (%)
Dandala et al. [5] TR22 + NLM180 41.94 23.19 29.87 25.24 16.10 19.66 44.61 29.31 35.38 22.99 16.83 19.43
Tran et al. [27] TR22 + NLM180 29.50 37.45 33.00 22.08 21.13 21.59 36.68 40.02 38.28 22.53 21.13 23.55
BL + GCA (Ours) TR22 + NLM180 32.89 41.06 36.51 24.66 21.35 22.87 40.57 42.44 41.47 28.15 22.42 24.95
sentences per drug label (144 vs. 27), with a smaller proportion of those sentences having gold annotations (23% vs.
51%). Test Set 2 is unique in that it contains annotations from only two sections, namely DRUG INTERACTIONS
and CLINICAL PHARMACOLOGY, the latter of which is not represented in TR22 (nor Test Set 1). Lastly, TR22,
Test Set 1, and Test Set 2 all vary with respect to the distribution of interaction types, with TR22, Test Set 1, and
Test Set 2 containing a higher proportion of PD, UN, and PK interactions respectively. Overall model performance
is assessed using a single metric defined as the average of entity recognition and relation extraction performance
across both test sets.
4 RESULTS AND DISCUSSION
In order to assess model performance with confidence intervals and draw conclusions based on statistical
significance, we perform a technique called bootstrap ensembling proposed by Kavuluru et al. [10]. That is, for
each neural network (NN), we train a pool of 30 models each with a different set of randomly initialized weights
and training-development set split. Performance of the NN is evaluated based on computing the 95% confidence
interval around the mean F1 of N = 100 ensembles, where each ensemble is assembled from a set of ten models
randomly sampled from the pool. This approach allows us to better assess average performance which is a
nontrivial task given the high variance nature of models learned with limited training data. Our method for
model ensembling (by “voting”) is described in Section 3.6.
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We present the main results of this study in Table 4 where we compare our prior efforts using strictly BiLSTMs
(BL) and our current best results with graph convolutions (GCA). BL with TR22 and NLM180 as training data
corresponds to our prior best at 28.16% overall F1, while GCA with TR22, NLM180, and DDI2013 as training data
represents our current best at 32.18% overall F1 based on graph convolutions. Here, we observe a 4 point gain
in overall F1 (statistically significant at 95% confidence level based on non-overlapping confidence intervals),
with most gains owing to a substantial improvement in entity recognition performance. We note that GCA is
more precision focused while BL is more recall focused; moreover, GCA tends to exhibit better performance
on Test Set 1, while BL tends to exhibit better performance on Test Set 2. This hints that the two architectures
are highly complementary and may work well in combination. Indeed, when combined via ensembling, we
observe a major performance gain across almost all measures. Here, for each ensemble, we sample five models
from each pool of models (GCA and BL) for a total of ten models to ensure that results remain comparable. The
resulting hybrid model exhibits the best performance overall, improving over the prior best by two points and
over the current best by six points in overall F1 at 34.61%. These differences are statistically significant at the
95% confidence level. Next, we highlight that a main benefit of the GCA model is that it operates well with very
small amounts of training data, as evident by the almost 2 absolute point improvement over the BiLSTM model
when trained solely on TR22. These gains tend to be less notable when we involve examples from NLM180 and
DDI2013. Lastly, we note that GCA (graph convolution with attention-gating) performs better than the standard
GC (graph convolution without attention-gating) by two absolute points in overall F1 with improvements that are
consistent across all metrics. We present a comparison of our results with other works in Table 5. We omit results
by Tang et al. [26] as they are not directly comparable to ours given the stark difference in available training data.
When training on strictly TR22 and NLM180 (thus being comparable to most prior work), our model exhibits
state-of-the-art performance across all metrics on either test sets.
We present Figures 3 and 4 to illustrate error cases to be discussed later in Section 5. In additional to actual and
predicted annotations, these figures include a sigmoid gating activity visualization for edges in the dependency
tree. The visualization serves two purposes. First, it confirms the intuition for this particular design and, second,
provides a means to interpret model decisions. That is, we can observe the importance of each edge in the
dependency tree as deemed by the network for a particular example. In Figure 3, for example, we can observe
that for the target word “digoxin” (which is a precipitant, the second occurrence in the sentence), the phrase
“use”, “concomitantly”, and “with” show very high activity. Likewise, signal flow from “hemodynamic” to “effects”
is strong, and vice versa. Less important words such as articles appear to receive less incoming activity overall,
even through self-loops.
5 ERROR ANALYSIS
In this section, we perform error analysis to identify challenging cases typically resulting in erroneous predictions
by the model. One major source of difficulty for the model is boundary detection in cases of multi-word entities.
Errors of this type are especially prominent in case of effect mentions which may manifest as potentially long
noun phrases. Phrases with conjunctions or punctuation marks (or a combination of) may also present an obstacle
for the model; for example, an effect expressed as “serious and/or life threatening reaction” may instead be
predicted as simply “life threatening reaction.” Figure 3 shows a general case of this error where the model
recognizes “potentiation of adverse hemodynamic effects” as the effect while the ground truth identifies the effect
as simply “adverse hemodynamic effects.” This leads to both a false positive and a false negative for both the
NER and the RE evaluation. We note that, given the potentially limitless ways an effect may be expressed, any
disagreement among annotators (for cases beyond those addressed in annotator guidelines) during the initial
annotation process will lead to inconsistent ground truth data and thus negatively affect downstream model
performance. As an example, consider the following two sentences that appear in TR22: “Co-administration of
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PREDICTED ACTUAL
Fig. 3. An example sentence from the drug label for Savella
along with the resulting prediction and ground truth labels.
Red arrows indicate interaction outcome.
SIGMOID GATE
ACTIVITY
PREDICTED ACTUAL
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43
57
Fig. 4. An example sentence from the drug label for Aubagio
along with the resulting prediction and ground truth labels.
Red arrows indicate interaction outcome, where C54357 is
a PK label corresponding to the NCI Thesaurus code for
“Increased Concomitant Drug Level.”
SAMSCA with potent CYP3A inducers ..” and “For patients chronically taking potent inducers of CYP3A, ..”
Here, one sentence is annotated such that potent is included as part of the precipitant expression, while another
is annotated such that this modifier is excluded.
Mixed signals and noisy labels in general tend to be an issue especially when there is limited training data as
deep learning models are prone to overfitting. When evaluating on purely effect mentions, we obtain a micro-F1
score of 66% (54% Precision, 87% Recall). However, the micro F1 is 87% when ignoring the starting boundary
offset and 86% when ignoring the ending boundary offset during evaluation corresponding to roughly 20 absolute
micro-F1 gain in performance. When applying the same looser evaluation criteria to triggers and precipitants, the
gains are only ≈ 6% and ≈ 5% respectively. Thus there is immense potential for improving entity recognition of
effect mentions if we can better handle boundary detection, possibly via rule-based methods or post-processing
adjustments, with the added benefit of improving consequence prediction performance for PD interactions.
Precipitants interacting with the label drug being mentioned multiple times may also cause issues for the
model. As an example, consider the sentence presented in Figure 3. Our model identifies both mentions of the
precipitant “Digoxin” as being involved in an interaction with the drug Savella; however, the ground truth more
specifically recognizes the second mention as the sole precipitant. This results in an additional false positive with
respect to both NER and RE evaluation. Lastly, there are cases where the model will mistake a mention subtly
referring to the label drug as a precipitant. This is a common occurrence in cases where the label drug is not
referred to by name, but by a class of drugs. Typically, identifying a mention as a reference to the drug label
beforehand will disqualify it from being predicted as a precipitant. While we do use a lexicon of drug names
mapped to drug synonyms and drug classes to identify these indirect mentions, it is not exhaustive for all drugs.
For example, within the label of the drug Lexapro, consider the sentence “Altered anticoagulant effects, including
increased bleeding, have been reported when SSRIs and SNRIs are coadministered with warfarin.” Here, the model
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recognized SSRI and SNRI as precipitants. This is incorrect, however, as Lexapro is an SSRI and these mentions
are more than likely referring to Lexapro. Without this information, the model likely assumes that it is an implicit
case where the label drug is not mentioned and therefore assume all drug mentions are precipitants. Hence,
curating a more exhaustive lexicon for indirectly mentions of the label drug will improve overall performance.
Table 6. Confusion matrix for interaction type
Predicted
PD PK UN
Ac
tu
al PD 788 37 68
PK 57 353 147
UN 170 10 599
Lastly, we describe a source of difficulty stemming from incorrectly classifying interaction types. Figure 4
presents an example sentence where our model mistakes PK for PD interactions and a trigger mention for an effect
mention. As PD and PK interactions tend to frequently co-occur with effect and trigger mentions respectively,
predicted annotations tend to be polarized toward one pair (PD with effect) or the other (PK with trigger). Hence,
differentiating between types of interactions for each recognized precipitant is another interesting class of error.
Among all correctly recognized precipitants (based purely on boundary detection), we analyzed cases where one
type of interaction, among PD, PK, and Unspecified (UN), is mistaken for another via the confusion matrix in
Table 6. Clearly, many errors are due to cases where (1) we mistake unspecified precipitants for PD precipitants
and (2) we mistake PK precipitants for unspecified precipitants. We conjecture that making precise implicit
connections (not only whether there is evidence in the form of trigger words or phrases, but whether the evidence
concerns the particular precipitant) is highly nontrivial. Likely, this aspect may be improved by inclusion of more
high quality training data. Confusion between trigger and effect mentions is less concerning; among more than
1000 cases, there are six cases where we mistake effect for trigger and 20 cases where we mistake trigger for effect.
6 CONCLUSION
In this study, we proposed an end-to-end method for extracting drugs and their interactions from drug labels,
including interaction outcome in the case of PK and PD interactions. The method involved composing various
intermediate representations including sequential and graph based context, where the latter is produced using
a novel attention-gated version of the graph convolution over dependency parse trees. The so called graph
convolutionwith attention-gating (GCA), alongwith transfer learning via serial pre-training using other annotated
DDI datasets including DDI2013, resulted in an improvement over our original TAC challenge entry by up to 6
absolute F1 points overall. Among comparable studies (based on training data composition), our method exhibits
state-of-the-art performance across all metrics and test sets. Future work will focus on curating more quality
training data and leveraging semi-supervised methods overcome the scarcity in training data.
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